OGI / Organigram Global Inc. - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, James Yamanaka, Chief Executive Officer of Organigram Global Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Global Inc.

Organigram Reports Second Quarter Fiscal 2026 Results

Organigram Reports Second Quarter Fiscal 2026 Results TORONTO, ON, May 12, 2026 - Organigram Global Inc.

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 17 ORGANIGRAM GLOBAL INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

Q2 Fiscal 2026

INTRODUCTION This Management’s Discussion and Analysis dated May 12, 2026 (this "MD&A") should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Global Inc.

Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026

Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026 TORONTO-(BUSINESS WIRE)- May 6, 2026 - Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of

Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities

Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities TORONTO, Ontario and BERLIN, Germany – April 15, 2026 – Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of

Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting TORONTO, Ontario – March 30, 2026 – Organigram Global Inc.

ORGANIGRAM GLOBAL INC. (the “Company”) Annual General and Special Meeting of Shareholders Held on March 30, 2026 REPORT OF VOTING RESULTS

ORGANIGRAM GLOBAL INC. (the “Company”) Annual General and Special Meeting of Shareholders Held on March 30, 2026 REPORT OF VOTING RESULTS Pursuant to section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters decided at the 2025 annual general and special meeting of shareholders of the Company held on March 30, 2026 (the “Meeting”). All matter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH ISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Reco

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH ISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Recommending Shareholders Vote FOR the Transaction Resolution TORONTO—(BUSINESS WIRE)— March 23, 2026 Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting Special Meeting to Approve Acquisition of Sanity Group GmbH

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting Special Meeting to Approve Acquisition of Sanity Group GmbH TORONTO, Ontario – March 10, 2026 – Organigram Global Inc.

NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 30, 2026 MANAGEMENT INFORMATION CIRCULAR Dated: February 23, 2026 Message to Shareholders

Exhibit 99.1 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 30, 2026 and MANAGEMENT INFORMATION CIRCULAR Dated: February 23, 2026 Message to Shareholders Dear Shareholders, The board of directors (the “Board”) of Organigram Global Inc. (the “Company” or “Organigram”) is pleased to invite you to our annual general and special meeting (the “Meeting”) of the holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

FORM OF PROXY (“PROXY”) ORGANIGRAM GLOBAL INC. (the "Company") Annual and Special Meeting March 30, 2026 at 10:00 AM (Canada/Eastern Standard) 333 Bay Street, Suite 3400, Toronto, Ontario CONTROL NUMBER: «CONTROL_NUMBER» SECURITY CLASS: Common Shares

Exhibit 99.2 ORGANIGRAM GLOBAL INC. (the "Company") Annual and Special Meeting March 30, 2026 at 10:00 AM (Canada/Eastern Standard) 333 Bay Street, Suite 3400, Toronto, Ontario (the "Meeting") Proxy Voting – Guidelines and Conditions THIS PROXY IS SOLICITED BY OR ON BEHALF OF THE MANAGEMENT OF THE COMPANY. THIS PROXY SHOULD BE READ IN CONJUNCTION WITH THE MEETING MATERIALS PRIOR TO VOTING. If you

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity FAST™-powered SHRED Shotz extends the SHRED brand into shot-sized beverages

Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity FAST™-powered SHRED Shotz extends the SHRED brand into shot-sized beverages Toronto, Ontario - March 5, 2026 - Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

FORM 51-102F3 MATERIAL CHANGE REPORT

FORM 51-102F3 MATERIAL CHANGE REPORT Item One – Name and Address of Company Organigram Global Inc.

Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia Launch aligns with rising Australian demand for alternatives to flower and strengthens Organigram’s global medical cannabis presence

Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia Launch aligns with rising Australian demand for alternatives to flower and strengthens Organigram’s global medical cannabis presence TORONTO, ONTARIO, Canada — February 24, 2026 — Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Dated February 18, 2026

Dated February 18, 2026 Share Sale and Purchase Agreement regarding Shares in Sanity Group GmbH Hogan Lovells International LLP Karl-Scharnagl-Ring 5, 80539 Munich [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential.

PricewaterhouseCoopers LLP PwC Tower, 18 York Street, Suite 2500, Toronto, Ontario, Canada M5J 0B2 T: +1 416 863 1133, F: +1 416 365 8215, Fax to mail: [email protected], www.pwc.com/ca “PwC” refers to PricewaterhouseCoopers LLP, an Onta

a3organigram-changexinxa PricewaterhouseCoopers LLP PwC Tower, 18 York Street, Suite 2500, Toronto, Ontario, Canada M5J 0B2 T: +1 416 863 1133, F: +1 416 365 8215, Fax to mail: catoronto18yorkfax@pwc.

SUBSCRIPTION AGREEMENT BT DE INVESTMENTS INC. ORGANIGRAM GLOBAL INC. February 18, 2026

SUBSCRIPTION AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM GLOBAL INC. February 18, 2026 [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. Redacted information is denoted by “[*]” in this exhibit. The Company agrees to furnish supplementally an unredacted copy of the ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

PKF O’CONNOR DAVIES LLP 245 Park Avenue, New York, NY 10167 I Tel: 212.867.8000 or 212.286.2600 I Fax: 212.286.4080 I www.pkfod.com PKF O’Connor Davies LLP is a member firm of the PKF International Limited network of legally independent firms and doe

a4pkfodresponseletter-up PKF O’CONNOR DAVIES LLP 245 Park Avenue, New York, NY 10167 I Tel: 212.

NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: PKF O’Connor Davies, LLP (“Predecessor Auditor”) AND TO: PricewaterhouseCoopers LLP (“Successor Auditor”) AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services

a2updatednoticetopredece NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: PKF O’Connor Davies, LLP (“Predecessor Auditor”) AND TO: PricewaterhouseCoopers LLP (“Successor Auditor”) AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of

NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: PKF O’Connor Davies, LLP (“Predecessor Auditor”) AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Albert

a1noticeofchangeinaudito NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: PKF O’Connor Davies, LLP (“Predecessor Auditor”) AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commission Autorité

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share a

Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. Toronto, Ontario, February 19, 2026 – Organigram Global Inc. (NASDAQ: O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company with Leadership Positions in the World’s Two Largest Fede

organigram-02182026 Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company with Leadership Positions in the World’s Two Largest Federally Legal Cannabis Markets  Organigram to acquire Sanity Group for up-front consideration of €113.

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 16 ORGANIGRAM GLOBAL INC.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Global Inc.

Organigram Reports First Quarter Fiscal 2026 Results Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin.

Organigram Reports First Quarter Fiscal 2026 Results Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, James Yamanaka, Chief Executive Officer of Organigram Global Inc.

DECEMBER 31, 2025

INTRODUCTION This Management’s Discussion and Analysis dated February 10, 2026 (this "MD&A") should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 TORONTO-(BUSINESS WIRE)- February 3, 2026 - Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: ORGANIGRAM GLOBAL INC. Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that the Notice of Record and Meeting Dates was sent to The Canadian Depo

noticeofmeetingandrecord VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: ORGANIGRAM GLOBAL INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Extends Innovation Investment with Phylos

Organigram Extends Innovation Investment with Phylos Expanded agreement expected to deliver Organigram enhanced operational security, priority access to selected genetics, and a robust seed pipeline through 2030 Key Highlights: •US$3 million investment accelerates Organigram’s innovation strategy, providing access to next-generation genetics and strengthening its leadership in seed-based cultivation.

Q4 Fiscal 2025

INTRODUCTION This Management’s Discussion and Analysis dated December 16, 2025 (this “MD&A”), should be read in conjunction with the audited annual consolidated financial statements (the “Financial Statements”) of Organigram Global Inc.

PKF O’CONNOR DAVIES LLP 245 Park Avenue, New York, NY 10167 I Tel: 212.867.8000 or 212.286.2600 I Fax: 212.286.4080 I www.pkfod.com PKF O’Connor Davies LLP is a member firm of the PKF International Limited network of legally independent firms and doe

a2025pkfconsentexhibit99 PKF O’CONNOR DAVIES LLP 245 Park Avenue, New York, NY 10167 I Tel: 212.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2025 Commission File Number 001-38885 ORGANIGRAM GLOBAL INC. (Exact name of Registrant as specifie

TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 8 Consolidated Statements of Financial Position 9 Consolidated Statements of Operations and Comprehensive Loss 10 Consolidated Statements o

TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 8 Consolidated Statements of Financial Position 9 Consolidated Statements of Operations and Comprehensive Loss 10 Consolidated Statements of Changes in Equity 11 Consolidated Statements of Cash Flows 12 Notes to the Consolidated Financial Statements 13 – 44 December 11, 2025 Management’s Responsibility for the Financial Statements The accompanying consolidated financial statements of Organigram Global Inc.

ORGANIGRAM GLOBAL INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and revis

exhibit997-thecompanysco ORGANIGRAM GLOBAL INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and revised on September 26, 2025. The objective of this Code is to provide guidelines for maintaining the integrity, reputation, hone

2025 ANNUAL INFORMATION FORM OF ORGANIGRAM GLOBAL INC. For the Year Ended September 30, 2025 Dated December 16, 2025 TABLE OF CONTENTS ANNUAL INFORMATION FORM ...........................................................................................

annualinformationform202 2025 ANNUAL INFORMATION FORM OF ORGANIGRAM GLOBAL INC. For the Year Ended September 30, 2025 Dated December 16, 2025 TABLE OF CONTENTS ANNUAL INFORMATION FORM ............................................................................................................ 3 FORWARD-LOOKING STATEMENTS ..............................................................................

CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Organigram Global Inc. (the "Company") on Form 40-F for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Peter Amirault, Executive Chair of the Company, certify, pursuan

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 99.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Greg Guyatt, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Global Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

Organigram Reports Record Fourth Quarter and Fiscal 2025 Results Record annual revenue, adjusted EBITDA1, and international sales.

Organigram Reports Record Fourth Quarter and Fiscal 2025 Results Record annual revenue, adjusted EBITDA1, and international sales.

2 0 2 5 ANNUAL REPORT We are our vision Our Year in Focus Fiscal 2025 was a year of record growth, coast-to-coast market leadership, and expanding international sales, strengthening our foundation. To be a respected global cannabis leader, rooted in

annualreport-2025 2 0 2 5 ANNUAL REPORT We are our vision Our Year in Focus Fiscal 2025 was a year of record growth, coast-to-coast market leadership, and expanding international sales, strengthening our foundation.

ORGANIGRAM GLOBAL INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was adopted by the

exhibit971-policyforther ORGANIGRAM GLOBAL INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was adopted by the board of directors (the “Board”) of the Corporation on November 30, 2023 and last reviewed and revised on September 26, 2025

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 99.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Peter Amirault, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Global Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in lig

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 TORONTO--(BUSINESS WIRE)--December 5, 2025--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1,

exhibit991-pressreleased Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 TORONTO-(BUSINESS WIRE)-December 5, 2025-Organigram Global Inc.

FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc. (the “Company”) 145 King Street West, Suite 1400 Toronto, ON, M5H 1J8 ITEM 2 - Date of Material Change November 25, 2025 ITEM 3 - News Release The Compan

exhibit991-materialchang FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Announces Appointment of Chief Executive Officer

Organigram Announces Appointment of Chief Executive Officer November 25, 2025 – Toronto, Ontario - Organigram Global Inc.

Majority of Canadians Want Carney Government to Catch Up on Cannabis Policy Three in five Canadians say it’s time legal cannabis industry was treated as an economic opportunity

Majority of Canadians Want Carney Government to Catch Up on Cannabis Policy Three in five Canadians say it’s time legal cannabis industry was treated as an economic opportunity TORONTO – OCTOBER 29, 2025 – Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Global Announces Update to CEO Succession Plan

Organigram Global Announces Update to CEO Succession Plan October 21, 2025, Toronto, Ontario – Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep Brand debuts with innovative FAST™ nanoemulsion gummies and incorporates functional ingredients lik

Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep Brand debuts with innovative FAST™ nanoemulsion gummies and incorporates functional ingredients like caffeine, l-theanine, and chamomile extract to deliver on different mood states Toronto, Ontario, October 9, 2025 – Organigram Global Inc. (NASDAQ:

Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada’s GDP in 2024 New analysis shows cannabis as a national growth engine, aligning with Prime Minister Carney’s One Canadian Economy vision.

Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada’s GDP in 2024 New analysis shows cannabis as a national growth engine, aligning with Prime Minister Carney’s One Canadian Economy vision.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addres

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address o

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 21 ORGANIGRAM GLOBAL INC.

Q4-F23 (1)

INTRODUCTION This Management’s Discussion and Analysis dated August 13, 2025 (this "MD&A") should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Global Inc.

Organigram Reports Record Third Quarter Fiscal 2025 Results Second consecutive quarter of record revenue, strong adjusted EBITDA growth, Free Cash Flow, and continued international expansion

Organigram Reports Record Third Quarter Fiscal 2025 Results Second consecutive quarter of record revenue, strong adjusted EBITDA growth, Free Cash Flow, and continued international expansion TORONTO, ON, August 13, 2025 - Organigram Global Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Global Inc.

Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025

Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 TORONTO-(BUSINESS WIRE)—August 1, 2025 - Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio

Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio Toronto, Ontario – July 8, 2025: Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, announced today that its recently acquired beverage business, Collective Project, ha

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc. (the "Company") 145 King Street West, Suite 1400 Toronto, ON, M5H 1J8 ITEM 2 - Date of Material Change May 27, 2025 ITEM 3 - News Release The Company iss

FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

Organigram Global Announces CEO Succession Plan

Organigram Global Announces CEO Succession Plan •Beena Goldenberg, CEO to retire at the end of the Company’s fiscal year •Board of Directors expresses confidence in the Company’s strategic direction and leadership team •Comprehensive CEO selection process will be initiated to identify a successor Toronto (Business Wire) - May 27, 2025 - Organigram Global Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Global Inc.

Organigram Reports Record Second Quarter Fiscal 2025 Results

Organigram Reports Record Second Quarter Fiscal 2025 Results •Record gross revenue of $102.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Global Inc.

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 20 ORGANIGRAM GLOBAL INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

Q4-F23 (1)

INTRODUCTION This Management’s Discussion and Analysis dated May 12, 2025 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Global Inc.

Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California Wins gold medal for Blood Orange Yuzu & Vanilla and platinum medal for Mango Pineapple & Coconut

Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California Wins gold medal for Blood Orange Yuzu & Vanilla and platinum medal for Mango Pineapple & Coconut Toronto, Ontario – May 7, 2025: Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards Award recognizes exceptional export growth, product innovation, and global market leadership

Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards Award recognizes exceptional export growth, product innovation, and global market leadership Toronto, Ontario – May 5, 2025 Organigram Global Inc.

Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025

Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 TORONTO-(BUSINESS WIRE)- May 2, 2025 - Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p

Organigram Global Congratulates Mark Carney on Election Win

Organigram Global Congratulates Mark Carney on Election Win Urges new government to work with industry to help legal cannabis industry fuel Canada’s economic growth Toronto, Ontario – April 29, 2025 Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Organigram Global’s Products Recognized at the CNB Awards SHRED, Edison, and Trailblazer Recognized for Excellence in Branding and Product Innovation

Organigram Global’s Products Recognized at the CNB Awards SHRED, Edison, and Trailblazer Recognized for Excellence in Branding and Product Innovation Toronto, Ontario – April 24, 2025 Organigram Global Inc.

Organigram Global Shares Recording of its OG Investor Session OG Investor Session includes presentations from Organigram Global’s senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session

Organigram Global Shares Recording of its OG Investor Session OG Investor Session includes presentations from Organigram Global’s senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session TORONTO, Ontario – April 22, 2025 – Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future

New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future Clear majority believes Canada’s $7.

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ TORONTO, Ontario – April 2, 2025 – Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Organigram Enters U.S. Through Acquisition of Collective Project Beverages Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category

Organigram Enters U.S. Through Acquisition of Collective Project Beverages Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category Toronto, Ontario, April 1, 2025 – Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada’s #1 cannabis company by market share, i

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Certificate of Amendment Loi canadienne sur les sociétés par actionsCanada Business Corporations Act Certificat de modification Organigram Global Inc. 969981-3 Corporate name / Dénomination sociale Corporation number / Numéro de société Hantz Prosper

Certificate of Amendment Loi canadienne sur les sociétés par actionsCanada Business Corporations Act Certificat de modification Organigram Global Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence

Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence TORONTO, Ontario - March 26, 2025 – Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on March 24, 2025 REPORT OF VOTING RESULTS

ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on March 24, 2025 REPORT OF VOTING RESULTS Pursuant to section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters decided at the 2024 annual general and special meeting of shareholders of the Corporation held on March 24, 2025 (the “Meeting”).

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.

TSX TRUST Virtual Meeting Guide 1/2 Issuer Name ORGANIGRAM HOLDINGS INC. Meeting Date Time March 24, 2025 10:00AM EST This year we will be conducting a virtual meeting, giving you the opportunity to attend the meeting online, using your smartphone, t

Exhibit 99.3 TSX TRUST Virtual Meeting Guide 1/2 Issuer Name ORGANIGRAM HOLDINGS INC. Meeting Date Time March 24, 2025 10:00AM EST This year we will be conducting a virtual meeting, giving you the opportunity to attend the meeting online, using your smartphone, tablet or computer. You will be able to view a live webcast of the Meeting, ask questions and submit your votes in real time (where applic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment

Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment TORONTO, Ontario - March 3, 2025 - Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address

ORGANIGRAM HOLDINGS INC (the “Corporation”) Annual and Special Meeting March 24, 2025 at 10:00AM (Canada/Eastern Standard) Virtual Meeting at 10am EST (the “Meeting”) Proxy Voting – Guidelines and Conditions 1. THIS PROXY IS SOLICITED BY OR ON BEHALF

Exhibit 99.2 ORGANIGRAM HOLDINGS INC (the “Corporation”) Annual and Special Meeting March 24, 2025 at 10:00AM (Canada/Eastern Standard) Virtual Meeting at 10am EST (the “Meeting”) Proxy Voting – Guidelines and Conditions 1. THIS PROXY IS SOLICITED BY OR ON BEHALF OF THE MANAGEMENT OF THE CORPORATION. 2. THIS PROXY SHOULD BE READ IN CONJUNCTION WITH THE MEETING MATERIALS PRIOR TO VOTING. 3. If you

NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 24, 2025 MANAGEMENT INFORMATION CIRCULAR Dated: February 12, 2025

EX-99.1 Exhibit 99.1 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 24, 2025 and MANAGEMENT INFORMATION CIRCULAR Dated: February 12, 2025 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 24, 2025 NOTICE IS HEREBY GIVEN that an annual general and special meeting (the “Meeting”) of the holders (“Shareholders”) of common shares (“Commo

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidat

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 17 ORGANIGRAM HOLDINGS INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre

DECEMBER 31, 2024

INTRODUCTION This Management’s Discussion and Analysis dated February 11, 2025 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.

Organigram Reports First Quarter Fiscal 2025 Results

Organigram Reports First Quarter Fiscal 2025 Results •17% growth in net revenue to $42.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.

Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025

Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 TORONTO-(BUSINESS WIRE)—February 4, 2025 -Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre

Fiscal 2024

NOTE TO READER This Management’s Discussion and Analysis for the year ended September 30, 2024 is being refiled to correct errors in the outstanding share data table on page 34.

NOTICE The annual information form was inadvertently filed with the incorrect date on December 18, 2024 and is being re-filed. This replaces the previously filed version. 2024 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Year Ended Sep

Amended NOTICE The annual information form was inadvertently filed with the incorrect date on December 18, 2024 and is being re-filed.

CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Beena Goldenberg, Chief Executive Officer of the Company, cert

CERTIFICATION

EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Exhibit 99.1 CERTIFICATION I, Beena Goldenberg, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such state

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13(A) OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 Commission File Number 001-38885 ORGANIGRAM HOLDINGS INC. (Exact name of

Organigram Reports Fourth Quarter and Fiscal 2024 Results

Organigram Reports Fourth Quarter and Fiscal 2024 Results TORONTO, ON, December 20, 2024 - This earnings release replaces the previously filed earnings release to correct errors in the outstanding share data tables under the heading “CAPITAL STRUCTURE”.

CERTIFICATION

Exhibit 99.2 CERTIFICATION I, Greg Guyatt, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect

Organigram Reports Fourth Quarter and Fiscal 2024 Results

Organigram Reports Fourth Quarter and Fiscal 2024 Results •Fiscal 2024 net revenue of $159.

ORGANIGRAM HOLDINGS INC. Annual Report Electric Lemon JOLTS (1ct) Red Razz Chiller SONICS (2ct) THCV Super Sativa Oil (30 ml) A mainstream brand focused on truly innovative products. SHRED Captain Kush 7g pre-milled flower, SHRED Gnarberry Dartz, SHR

exhibit9911-annualreport ORGANIGRAM HOLDINGS INC. Annual Report Electric Lemon JOLTS (1ct) Red Razz Chiller SONICS (2ct) THCV Super Sativa Oil (30 ml) A mainstream brand focused on truly innovative products. SHRED Captain Kush 7g pre-milled flower, SHRED Gnarberry Dartz, SHRED X Tropic Thunder Heavies, SHRED’ems Wild Berry Blaze gummies, SHRED X Blueberry Blaster Rip-Strip hash 2 g, SHRED’ems Shar

ORGANIGRAM HOLDINGS INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and rev

ORGANIGRAM HOLDINGS INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and revised on September 26, 2024. The objective of this Code is to provide guidelines for maintaining the integrity, reputation, honesty, objectivity and im

Fiscal 2024

INTRODUCTION This Management’s Discussion and Analysis dated December 18, 2024 (this “MD&A”), should be read in conjunction with the audited annual consolidated financial statements (the “Financial Statements”) of Organigram Holdings Inc.

CERTIFICATION

Exhibit 99.1 CERTIFICATION I, Beena Goldenberg, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with re

TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 9 Consolidated Statements of Financial Position 10 Consolidated Statements of Operations and Comprehensive Loss 11 Consolidated Statements

TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 9 Consolidated Statements of Financial Position 10 Consolidated Statements of Operations and Comprehensive Loss 11 Consolidated Statements of Changes in Equity 12 Consolidated Statements of Cash Flows 13 Notes to the Consolidated Financial Statements 14 – 43 December 18, 2024 Management’s Responsibility for the Financial Statements The accompanying consolidated financial statements of Organigram Holdings Inc.

CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Beena Goldenberg, Chief Executive Officer of the Company, cert

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13(A) OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 Commission File Number 001-38885 ORGANIGRAM HOLDINGS INC. (Exact name of Registrant as specif

Consent of Independent Registered Public Accounting Firm The Board of Directors of Organigram Holdings Inc. We consent to the use of: • Our report dated December 18, 2024, on the consolidated financial statements of Organigram Holdings Inc. (the “Com

pkfconsent Consent of Independent Registered Public Accounting Firm The Board of Directors of Organigram Holdings Inc.

ORGANIGRAM HOLDINGS INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was reviewed by t

ORGANIGRAM HOLDINGS INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was reviewed by the board of directors (the “Board”) of the Corporation on September 26, 2024 (the “Effective Date”). Purpose This Policy has been adopted by the Board

2024 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Year Ended September 30, 2024 Dated December 11, 2024 TABLE OF CONTENTS ANNUAL INFORMATION FORM .........................................................................................

annualinformationform202 2024 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Year Ended September 30, 2024 Dated December 11, 2024 TABLE OF CONTENTS ANNUAL INFORMATION FORM ............................................................................................................ 3 FORWARD-LOOKING STATEMENTS ............................................................................

KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.kpmg.ca KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with K

kpmgconsent KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.

CERTIFICATION

Exhibit 99.2 CERTIFICATION I, Greg Guyatt, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect

FORM 51-102F3 MATERIAL CHANGE REPORT

FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre

SHARE PURCHASE AGREEMENT DECEMBER 6, 2024 TABLE OF CONTENTS

SHARE PURCHASE AGREEMENT DECEMBER 6, 2024 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 1 1.

Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024

Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 TORONTO-(BUSINESS WIRE)—December 11, 2024 -Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre

OGI / Organigram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 19803 (302) 656-1950 With a cop

Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share Transformational Acquisition Results in Cannabis Pure Play Leader, Coast-to-Coast Geographic Strength and Proven Excellence in Consumer-Focused Innovation, Cultivat

Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share Transformational Acquisition Results in Cannabis Pure Play Leader, Coast-to-Coast Geographic Strength and Proven Excellence in Consumer-Focused Innovation, Cultivation, Product Development, Extraction and Manufacturing • Combination results in #1 market share position in the Canadian recreational cannabis market1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre

Organigram Launches FAST™ Nanoemulsion Gummies

Organigram Launches FAST™ Nanoemulsion Gummies •Company Continues to Lead in Innovation with Launch of Edison Sonics Gummies Featuring Groundbreaking FAST™ Nanoemulsion Technology •Clinically Proven to Deliver up to ~50% Faster Onset, Improved Bioavailability and Nearly Double the Cannabinoid Delivery at Peak Effect Toronto, Ontario – November 26, 2024 - Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addr

Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment

Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment TORONTO, Ontario – September 3, 2024 – Organigram Holdings Inc.

OGI / Organigram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 19803 (302) 656-1950 With a cop

Organigram Reports Third Quarter Fiscal 2024 Results

Organigram Reports Third Quarter Fiscal 2024 Results •Net revenue of $41.1 million increased 25% over the prior year period •Adjusted EBITDA1 of $3.5 million versus $(2.9) million over the prior year period •Established European foothold with a strategic investment in Sanity Group, a leading German cannabis company •Completed landmark clinical study on FAST™ nanoemulsion technology showing faster

JUNE 30, 2024

INTRODUCTION This Management’s Discussion and Analysis dated August 13, 2024 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 18 ORGANIGRAM HOLDINGS INC.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology FAST™ Nanoemulsion Technology Expected to be a Competitive Advantage for Organigram’s Ingestible Portfolio

Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology FAST™ Nanoemulsion Technology Expected to be a Competitive Advantage for Organigram’s Ingestible Portfolio Toronto, Ontario, August 7, 2024 – Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address

Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024

Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024 TORONTO-(BUSINESS WIRE)—August 6, 2024 -Organigram Holdings Inc.

Organigram Announces Appointment of Craig Harris to Board of Directors

Organigram Announces Appointment of Craig Harris to Board of Directors TORONTO, July 29, 2024 - Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of p

Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos

Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos •The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and differentiated aromas and flavours.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of p

KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG Canada provides services t

KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.

NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102)

NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: PKF O’Connor Davies, LLP (“Successor Auditor”) AND TO: KPMG LLP (“Predecessor Auditor”) AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commis

July 5, 2024

July 5, 2024 Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commission Autorité des marchés financiers Nova Scotia Securities Commission Office of the Superintendent of Securities, Government of Prince Edward I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month June 2024 Commission File Number: 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month June 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of p

Organigram Invests in Sanity Group, a Leading German Cannabis Company Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany

Organigram Invests in Sanity Group, a Leading German Cannabis Company Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany Highlights: •Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher volumes and the intention to work together on the commercialization of Organigram’s brands and intellectual property (IP) in Germany.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of

Organigram Signs Three Year Supply Agreement with Avida Medical in UK

Organigram Signs Three Year Supply Agreement with Avida Medical in UK •Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement.

MARCH 31, 2024

INTRODUCTION This Management’s Discussion and Analysis dated May 14, 2024 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidat

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 17 ORGANIGRAM HOLDINGS INC.

Organigram Reports Second Quarter Fiscal 2024 Results

Organigram Reports Second Quarter Fiscal 2024 Results •21% growth in recreational net revenue year-over-year •First Jupiter private placement tranche closed adding $41.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of

Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024

Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 TORONTO-(BUSINESS WIRE)—May 8, 2024 -Organigram Holdings Inc.

NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102)

NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: KPMG LLP AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commission Autorité des marchés financiers Nova Scotia Securities Commission Office o

KPMG LLP

KPMG LLP 100 New Park Place, Suite 1400 ” 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the highest execut

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the highest executive gender diversity.

FORM 51-102F3 MATERIAL CHANGE REPORT

FORM 51-102F3 MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p

Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers.

Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers.

Organigram Successfully Closes Previously Announced Underwritten Public Offering Including over-allotment Company raises C$28.8 million in gross proceeds improving already strong balance sheet

Organigram Successfully Closes Previously Announced Underwritten Public Offering Including over-allotment Company raises C$28.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p

ORGANIGRAM HOLDINGS INC. as the Corporation TSX TRUST COMPANY as the Warrant Agent

Execution Version [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p

UNDERWRITING AGREEMENT

[Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential.

PROSPECTUS SUPPLEMENT (to the Short Form Base Shelf Prospectus dated October 6, 2023)

Filed Pursuant to General Instruction II.L of Form F-10 File No. 333-274686 No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus supplement, together with the short form base shelf prospectus to which it relates dated October 6, 2023, as amended or supplemented, and each document incorporated or deemed to be inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p

March 27, 2024

March 27, 2024 To: The United States Securities and Exchange Commission Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p

Indicative Term Sheet $25 million Treasury Offering Of Equity Units March 26, 2024

Filed pursuant to Rule 433 Registration Statement No. 333-274686 Issuer Free Writing Prospectus dated March 26, 2024 Relating to Prospectus dated October 6, 2023 Indicative Term Sheet $25 million Treasury Offering Of Equity Units March 26, 2024 The Units (as hereinafter defined) will be offered by way of a prospectus supplement to a final base shelf prospectus in each of the provinces and territor

Term Sheet Approximately $25 million Treasury Offering Of Equity Units March 27, 2024

Filed pursuant to Rule 433 Registration Statement No. 333-274686 Issuer Free Writing Prospectus dated March 27, 2024 Relating to Prospectus dated October 6, 2023 Term Sheet Approximately $25 million Treasury Offering Of Equity Units March 27, 2024 The Units (as hereinafter defined) will be offered by way of a prospectus supplement to a final base shelf prospectus in each of the provinces and terri

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p

Organigram Announces Launch of Overnight Marketed Public Offering

Organigram Announces Launch of Overnight Marketed Public Offering TORONTO-(BUSINESS WIRE)-March 26, 2024-Organigram Holdings Inc.

Organigram Announces Pricing of Overnight Marketed Public Offering

Organigram Announces Pricing of Overnight Marketed Public Offering TORONTO-(BUSINESS WIRE)-March 27, 2024-Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment North Carolina-based Open Book Extracts is a leading ingredient provider, product formulator and manufacturer of hemp-derived extracts and products.

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment North Carolina-based Open Book Extracts is a leading ingredient provider, product formulator and manufacturer of hemp-derived extracts and products. Toronto, Ontario – March 26, 2024 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-3888

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address

Organigram Receives Health Canada’s Final Redetermination on Jolts

Organigram Receives Health Canada’s Final Redetermination on Jolts TORONTO-(BUSINESS WIRE)—March 22, 2024 - Organigram Holdings Inc.

CT ORDER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION March 1, 2024 ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 Organigram Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty Revised Excise Framework Remains One of the Most Critical Reforms Required to Ensure the Long-Term Viability of the Cannabis Industry

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty Revised Excise Framework Remains One of the Most Critical Reforms Required to Ensure the Long-Term Viability of the Cannabis Industry Toronto, Ontario – February 28, 2024 - Organigram Holdings Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.

Form 52-109F2 Certification of Interim Filings Full Certificate

Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.

Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41

Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre

DECEMBER 31, 2023

INTRODUCTION This Management’s Discussion and Analysis dated February 13, 2024 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C

TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 15 ORGANIGRAM HOLDINGS INC.

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

Exhibit 99.1 Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024 TORONTO-(BUSINESS WIRE)-February 7, 2024-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres

Organigram Completes First Shipment to Germany, Extending its International Reach

Exhibit 99.1 Organigram Completes First Shipment to Germany, Extending its International Reach TORONTO-(BUSINESS WIRE)-January 31, 2024-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis today announced that it has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, a

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT BT DE INVESTMENTS INC. ORGANIGRAM HOLDINGS INC. January 23, 2024

EX-99.1 2 d30296dex991.htm EX-99.1 Exhibit 99.1 Confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934 has been requested for the redacted portions of this exhibit, and such confidential portions have been omitted and filed separately with the U.S. Securities and Exchange Commission. Execution Version AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT between BT DE INV

OGI / Organigram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 19803 (302) 656-1950 With a cop

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT BT DE INVESTMENTS INC. ORGANIGRAM HOLDINGS INC. January 23, 2024 TABLE OF CONTENTS

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM HOLDINGS INC. January 23, 2024 TABLE OF CONTENTS ARTICLE 1 DEFINITIONS AND INTERPRETATION Section 1.1 Definitions. 1 Section 1.2 Gender and Number. 9 Section 1.3 Headings, etc. 9 Section 1.4 Currency. 9 Section 1.5 Certain Phrases, etc. 9 Section 1.6 Accounting Terms. 9 Section 1.7 Schedules. 9 Section 1.8

Organigram Announces the First Tranche Closing from BAT Investment

Exhibit 99.1 Organigram Announces the First Tranche Closing from BAT Investment TORONTO-(BUSINESS WIRE)-January 24, 2024-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity investment (the “Inves

Organigram Announces Appointment of Karina Gehring to Board of Directors

Exhibit 99.1 Organigram Announces Appointment of Karina Gehring to Board of Directors TORONTO-(BUSINESS WIRE)-January 19, 2024-Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024. “We are thrilled to welcome Kar

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

EX-99.1 Exhibit 99.1 Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT TORONTO, Ontario – (BUSINESS WIRE) – January 18, 2024 – Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Sharehold

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Ad

Organigram Holdings Inc. Corporate name / Dénomination sociale Corporation number / Numéro de société

EX-99.3 Exhibit 99.3 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les sociétés par actions Organigram Holdings Inc. Corporate name / Dénomination sociale 969981-3 Corporation number / Numéro de société I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 178 of the Canada Business Corporations Act as

ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on January 18, 2024 REPORT OF VOTING RESULTS

EX-99.2 Exhibit 99.2 ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on January 18, 2024 REPORT OF VOTING RESULTS Pursuant to section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters decided at the 2023 annual general and special meeting of shareholders of the Corporation held on January 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Exhibit 99.1 Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of “Jupiter” Strategic Investment Pool TORONTO-(BUSINESS WIRE)-December 29, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading li